TNF and neoplasm: Infliximab, a monoclonal antibody targeting TNF-α, demonstrated no significant effect on primary tumor growth in a syngeneic BALB/c mouse model of 4T1 breast cancer; however, it reduced pulmonary metastasis incidence by 60%.